MARCKS protein overexpression is associated with poor prognosis in male breast cancer-Reference-Cited by-同舟云学术

MARCKS protein overexpression is associated with poor prognosis in male breast cancer

Published:2019-12-11 Issue:4 Volume:26 Page:513-522
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Manai Maroua¹²³¹,Abdeljaoued Syrine¹¹,Goucha Aïda¹,Adouni Olfa¹,Bettaieb Ilhem¹,Bouzaien Hatem⁴,Rahal Khaled⁴,Birnbaum Daniel³,Bertucci François³⁵⁶,Gamoudi Amor¹

Affiliation:

1. Department of Immuno-Histo-Cytology, Salah Azaiez Institute, Tunis, Tunisia

2. Laboratory of Biochemistry and Molecular Biology, Department of Biology, Faculty of Sciences, University of Tunis El Manar, Ariana, Tunisia

3. Predictive Oncology Laboratory, Cancer Research Center of Marseille, Paoli-Calmettes Institute, Aix-Marseille University, Marseille, France

4. Department of Surgery, Salah Azaiez Institute, Tunis, Tunisia

5. UFR of Medicine, Aix Marseille University, Marseille, France

6. Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference37 articles.

1. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival;Hill;Ann Epidemiol,2005

2. The rising incidence of male breast cancer;Speirs;Breast Cancer Res Treat,2009

3. How to treat male breast cancer;Czene;Breast Edinb Scotl,2007

4. Male breast cancer: a population-based comparison with female breast cancer;Anderson;J Clin Oncol,2010

5. MARCKS: a case of molecular exaptation;Ramsden;Int J Biochem Cell Biol,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of microRNAs as regulators of protein kinase C substrate MARCKS and MARCKSL1 in cancer;Experimental Cell Research;2024-01

2. Patent landscape highlighting therapeutic implications of peptides targeting myristoylated alanine-rich protein kinase-C substrate (MARCKS);Expert Opinion on Therapeutic Patents;2023-06-03

3. MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma;International Journal of General Medicine;2023-05

4. The Role of MARCKS in Metastasis and Treatment Resistance of Solid Tumors;Cancers;2022-10-08

5. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma;Cancer Investigation;2021-07-19